First Header Logo Second Header Logo

Connection

Anthony Atala to Carcinoma, Renal Cell

Back to Details
This is a "connection" page, showing publications Anthony Atala has written about Carcinoma, Renal Cell.
Anthony Atala
Connection Strength
6.714
Carcinoma, Renal Cell
  1. Atala A. Re: Estrogen Receptor ß Promotes Renal Cell Carcinoma Progression via Regulating LncRNA HOTAIR-miR-138/200c/204/217 Associated CeRNA Network. J Urol. 2019 09; 202(3):461.
    View in: PubMed
    Score: 0.634
  2. Atala A. Re: MYC Activation Cooperates with Vhl and Ink4a/Arf Loss to Induce Clear Cell Renal Cell Carcinoma. J Urol. 2018 01; 199(1):31.
    View in: PubMed
    Score: 0.558
  3. Atala A. Re: Inactivation of the PBRM1 Tumor Suppressor Gene Amplifies the HIF-Response in VHL-/- Clear Cell Renal Carcinoma. J Urol. 2017 10; 198(4):746-748.
    View in: PubMed
    Score: 0.550
  4. Atala A. Re: A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell Carcinoma. J Urol. 2016 07; 196(1):279-81.
    View in: PubMed
    Score: 0.503
  5. Atala A. Re: Infiltrating Neutrophils Promote Renal Cell Carcinoma (RCC) Proliferation via Modulating Androgen Receptor (AR)???c-Myc Signals. J Urol. 2016 06; 195(6):1947-9.
    View in: PubMed
    Score: 0.502
  6. Atala A. Re: Tumour-Suppressive MicroRNA-29s Directly Regulate LOXL2 Expression and Inhibit Cancer Cell Migration and Invasion in Renal Cell Carcinoma. J Urol. 2016 May; 195(5):1622.
    View in: PubMed
    Score: 0.498
  7. Atala A. Re: Human Schlafen 5 (SLFN5) is a Regulator of Motility and Invasiveness of Renal Cell Carcinoma Cells. J Urol. 2016 04; 195(4 Pt 1):1169.
    View in: PubMed
    Score: 0.496
  8. Atala A. Re: Circulating Biomarkers of One-Carbon Metabolism in Relation to Renal Cell Carcinoma Incidence and Survival. J Urol. 2015 Aug; 194(2):593-4.
    View in: PubMed
    Score: 0.473
  9. Atala A. Re: Fructose-1,6-bisphosphatase opposes renal carcinoma progression. J Urol. 2015 May; 193(5):1725-6.
    View in: PubMed
    Score: 0.465
  10. Atala A. Re: antitumoral effects of vasoactive intestinal peptide in human renal cell carcinoma xenografts in athymic nude mice. J Urol. 2014 Mar; 191(3):866-8.
    View in: PubMed
    Score: 0.427
  11. Atala A. Re: activation of HIF2a in kidney proximal tubule cells causes abnormal glycogen deposition but not tumorigenesis. J Urol. 2014 Feb; 191(2):555.
    View in: PubMed
    Score: 0.425
  12. Atala A. Re: Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts. J Urol. 2013 Sep; 190(3):1132.
    View in: PubMed
    Score: 0.414
  13. Atala A. Re: therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma. J Urol. 2011 Feb; 185(2):752.
    View in: PubMed
    Score: 0.352
  14. Glybochko PV, Alyaev YG, Khokhlachev SB, Fiev DN, Shpot EV, Petrovsky NV, Zhang D, Proskura AV, Yurova M, Matz EL, Wang X, Atala A, Zhang Y, Butnaru DV. 3D reconstruction of CT scans aid in preoperative planning for sarcomatoid renal cancer: A case report and mini-review. J Xray Sci Technol. 2019; 27(2):389-395.
    View in: PubMed
    Score: 0.152
  15. Atala A. Re: The Genomic Landscape of Renal Oncocytoma Identifies a Metabolic Barrier to Tumorigenesis. J Urol. 2017 08; 198(2):258-259.
    View in: PubMed
    Score: 0.136
  16. Atala A. Re: Infiltrating Macrophages Increase RCC Epithelial Mesenchymal Transition (EMT) and Stem Cell-Like Populations via AKT and mTOR Signaling. J Urol. 2017 01; 197(1):51-52.
    View in: PubMed
    Score: 0.130
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.